Why is Alkem Lab falling/rising?

As of 20-Aug, Alkem Laboratories Ltd is experiencing a slight decline in its stock price, currently at 5,384.35, reflecting a change of -9.15 (-0.17%). The stock has shown a trend reversal after two consecutive days of gains and is currently outperforming its sector by 0.25%. Despite trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, the stock's delivery volume has decreased by 14.62% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has gained 0.17%, while its performance over the past month shows a significant increase of 7.66%. However, year-to-date, the stock is down 4.37%, and over the past year, it has declined by 6.03%, which contrasts with its 3-year and 5-year returns of 83.27% and 88.52%, respectively.
In the broader market context, the Sensex has outperformed Alkem Laboratories Ltd, gaining 1.64% over the past week and 4.76% year-to-date. The company exhibits strong management efficiency with a high return on equity (ROE) of 17.69% and a low debt-to-equity ratio, suggesting financial stability. However, concerns about long-term growth persist, as net sales and operating profit have only grown at annual rates of 9.38% and 9.03% over the last five years. Additionally, a decrease in promoter confidence, with a 2.09% reduction in their stake, may signal potential issues regarding the company's future prospects, contributing to the stock's recent downward movement.